https://www.captis.com/wp-content/uploads/2021/12/Breast-cancer-cells.jpg9731280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-12-01 03:45:112021-12-01 03:53:51US FDA grants priority review to AstraZeneca’s sNDA for breast cancer therapy
https://www.captis.com/wp-content/uploads/2021/12/stomach-pain-gf911737db_1280.jpg8531280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-12-01 03:40:042021-12-01 03:53:59AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohn’s disease
https://www.captis.com/wp-content/uploads/2021/11/Untitled.jpg10431280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-11-30 02:11:512021-11-30 02:55:26Valneva, IDT Biologika partner to produce Covid-19 vaccines
https://www.captis.com/wp-content/uploads/2021/11/Cancer-1.jpg10181280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-11-29 03:59:062021-11-29 04:57:11US FDA approves Avacta Group’s IND application for AVA6000
https://www.captis.com/wp-content/uploads/2021/11/7273434238_f1349b8ec8_o.jpg9601280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-11-29 02:26:282021-11-29 02:57:12Quell raises $156m Series B funds to develop cell therapies
https://www.captis.com/wp-content/uploads/2021/11/vaccination-gb3ff77437_1280.jpg8521280CAPTIShttps://www.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-11-26 02:17:472021-11-26 02:53:14CHMP recommends use of Pfizer-BioNTech’s Covid-19 vaccine in children
https://www.captis.com/wp-content/uploads/2021/12/vaccination-gf54d67f42_1280.jpg 854 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-12-03 01:09:062021-12-03 01:53:10EMA begins rolling review of Valneva’s Covid-19 vaccine candidate VLA2001
https://www.captis.com/wp-content/uploads/2021/12/acne-gff2069a12_1280.jpg 853 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-12-02 00:31:372021-12-02 00:54:37Sanofi agrees to buy Austria-based Origimm Biotechnology
https://www.captis.com/wp-content/uploads/2021/12/Breast-cancer-cells.jpg 973 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-12-01 03:45:112021-12-01 03:53:51US FDA grants priority review to AstraZeneca’s sNDA for breast cancer therapy
https://www.captis.com/wp-content/uploads/2021/12/stomach-pain-gf911737db_1280.jpg 853 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-12-01 03:40:042021-12-01 03:53:59AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohn’s disease
https://www.captis.com/wp-content/uploads/2021/11/Untitled.jpg 1043 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-11-30 02:11:512021-11-30 02:55:26Valneva, IDT Biologika partner to produce Covid-19 vaccines
https://www.captis.com/wp-content/uploads/2021/11/Gilead-30thNov.jpg 534 800 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-11-29 22:38:432021-11-29 22:53:29Gilead Sciences selects AWS as preferred cloud provider
https://www.captis.com/wp-content/uploads/2021/11/Cancer-1.jpg 1018 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-11-29 03:59:062021-11-29 04:57:11US FDA approves Avacta Group’s IND application for AVA6000
https://www.captis.com/wp-content/uploads/2021/11/7273434238_f1349b8ec8_o.jpg 960 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-11-29 02:26:282021-11-29 02:57:12Quell raises $156m Series B funds to develop cell therapies
https://www.captis.com/wp-content/uploads/2021/11/vaccination-gb3ff77437_1280.jpg 852 1280 CAPTIS https://www.captis.com/wp-content/uploads/2021/01/captis_full_large.png CAPTIS2021-11-26 02:17:472021-11-26 02:53:14CHMP recommends use of Pfizer-BioNTech’s Covid-19 vaccine in children